Cat Packer

Dr. Cat Packer is committed to innovative research in the field of drug policy and legal regulation. As a Professor of Practice at the University of Arizona Law, she brings a wealth of experience and expertise to her role. Dr. Packer also serves as the director of drug markets and legal regulation at the Drug Policy Alliance, where she plays a pivotal role in shaping progressive drug policies. In addition to her work at the University of Arizona, Dr. Packer is a distinguished cannabis policy practitioner in residence at The Ohio State University Moritz College of Law's Drug Enforcement and Policy Center. Her contributions to the field are widely recognized, and she has been a trailblazer in cannabis regulation. Notably, she was the first person of color in the United States to lead a medical and adult-use cannabis regulatory program, serving as the inaugural Executive Director of the City of Los Angeles Department of Cannabis Regulation from 2017 to 2022. Dr. Packer's dedication to social justice and equity has earned her recognition as a social justice honoree by EBONY magazine. Her work is characterized by a commitment to creating fair and equitable drug policies that address the needs of diverse communities. Her leadership in Los Angeles set a precedent for inclusive and effective cannabis regulation, and her insights continue to influence policy discussions nationwide. A proud alumna of The Ohio State University, Dr. Packer's academic and professional journey reflects her passion for advancing drug policy reform. Her unique perspective and experience make her a sought-after voice in the field, and she continues to inspire future generations of legal scholars and practitioners. Dr. Packer's contributions extend beyond academia and policy-making; she is a dedicated advocate for social change and community empowerment. Her work emphasizes the importance of inclusive policy frameworks that prioritize public health and social equity. Through her leadership and advocacy, Dr. Packer is helping to shape a more just and equitable future in drug policy and regulation.